Kewitz S[Author] - Search Results

Year	Number of Results
1995	1
2012	2
2013	4
2014	2
2015	2
2016	2
2021	0

1

Prognostic Biomarkers for Hodgkin Lymphoma.

Staege MS, Kewitz S, Bernig T, Kühnöl C, Mauz-Körholz C. Staege MS, et al. Among authors: kewitz s. Pediatr Hematol Oncol. 2015;32(7):433-54. doi: 10.3109/08880018.2015.1071903. Epub 2015 Sep 18. Pediatr Hematol Oncol. 2015. PMID: 26380871 Review.

2

Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.

Kewitz S, Volkmer I, Staege MS. Kewitz S, et al. Cancer Growth Metastasis. 2013 Aug 8;6:35-52. doi: 10.4137/CGM.S11113. eCollection 2013. Cancer Growth Metastasis. 2013. PMID: 24665206 Free PMC article. Review.

3

Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.

Hermes N, Kewitz S, Staege MS. Hermes N, et al. Among authors: kewitz s. Curr Cancer Drug Targets. 2016;16(5):400-14. doi: 10.2174/1568009616666151222151818. Curr Cancer Drug Targets. 2016. PMID: 26694250 Review.

4

Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.

Kewitz S, Kurch L, Volkmer I, Staege MS. Kewitz S, et al. Tumour Biol. 2016 Jun;37(6):8229-37. doi: 10.1007/s13277-015-4705-3. Epub 2015 Dec 30. Tumour Biol. 2016. PMID: 26718211

5

Expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) in tumor cells.

Staege MS, Müller K, Kewitz S, Volkmer I, Mauz-Körholz C, Bernig T, Körholz D. Staege MS, et al. Among authors: kewitz s. PLoS One. 2014 Feb 24;9(2):e89577. doi: 10.1371/journal.pone.0089577. eCollection 2014. PLoS One. 2014. PMID: 24651368 Free PMC article.

6

Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.

Winkler C, Steingrube DS, Altermann W, Schlaf G, Max D, Kewitz S, Emmer A, Kornhuber M, Banning-Eichenseer U, Staege MS. Winkler C, et al. Among authors: kewitz s. Cancer Immunol Immunother. 2012 Oct;61(10):1769-79. doi: 10.1007/s00262-012-1239-z. Epub 2012 Mar 15. Cancer Immunol Immunother. 2012. PMID: 22419371

7

Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells.

Kewitz S, Bernig T, Staege MS. Kewitz S, et al. Leuk Res. 2012 Jun;36(6):773-8. doi: 10.1016/j.leukres.2012.02.021. Epub 2012 Mar 17. Leuk Res. 2012. PMID: 22424710

8

Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin's Lymphoma Cells.

Kewitz S, Staege MS. Kewitz S, et al. Front Oncol. 2013 Jul 10;3:179. doi: 10.3389/fonc.2013.00179. eCollection 2013. Front Oncol. 2013. PMID: 23847767 Free PMC article.

9

Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin's lymphoma cells.

Kewitz S, Stiefel M, Kramm CM, Staege MS. Kewitz S, et al. Leuk Res. 2014 Jan;38(1):138-43. doi: 10.1016/j.leukres.2013.11.001. Epub 2013 Nov 13. Leuk Res. 2014. PMID: 24284332

10

Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells.

Kewitz S, Staege MS. Kewitz S, et al. PLoS One. 2013;8(2):e55897. doi: 10.1371/journal.pone.0055897. Epub 2013 Feb 11. PLoS One. 2013. PMID: 23409080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results